Studies have also shown that patients with type 2 diabetes mellitus and those with NAFLD have higher serum levels of this type of selenoprotein than healthy controls [141,142,143]. The gene discussed is SELENOS; the disease is metabolic dysfunction-associated steatotic liver disease.